Moore John R

Moore John R is listed in filings as General Counsel at Edgewise Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 14, 2025, including sale activity. Recent filings connect the profile to Edgewise Therapeutics, Inc. (EWTX). The current snapshot covers public activity from Aug 14, 2024 to Aug 14, 2025. Reported amounts are shown as $2.2M to $31.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.